Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that their Chief Executive Officer, Rik Deitsch, was interviewed by Chris Castaldo of Wall Street Buy Sell Hold.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130815005509&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130815005509&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment